Investors are running into Viking Therapeutics (NASDAQ: VKTX) this week after an incident of drug-induced liver injury pushed Pfizer (NYSE:...
Read moreThe Hang Seng Index pulled back on Wednesday, even after China published strong economic numbers despite the ongoing trade war...
Read moreA wave of caution washed over Asian financial markets on Wednesday, pulling major indices lower as investors contended with lingering...
Read moreIndian equity benchmarks relinquished some ground in early trading on Wednesday, April 16, as investors appeared to book profits following...
Read moreTesco share price has bounced back in the last three straight days as investors cheer its recent financial results. After...
Read moreThe Super Micro Computer stock price remains in a consolidation phase this year as investors maintain their concerns about the...
Read moreEuropean stock markets retreated at the open on Wednesday, snapping a two-day winning streak as persistent uncertainty over US trade...
Read moreGoogle stock price has crashed by over 23% from its highest point this year, moving into a bear market. Alphabet...
Read morePlug Power stock price has crashed to a record low, moving from a record high of $75.45 in January 2021...
Read moreTechnology companies pick China for production primarily because it offers lower labour costs.That’s the widespread conception, or perhaps a “misconception”...
Read moreDisclaimer: EarningsMastery.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.